Does Mounjaro Cause Constipation — and What Can You Do About It?

Step 1: Understanding why tirzepatide slows the gut

Mounjaro works partly by activating GIP and GLP-1 receptors, which among other things slows gastric emptying, food leaves the stomach more slowly, which helps you feel full for longer. That same slowdown continues further down the digestive tract for many people, reducing how often the bowel contracts. If you are wondering whether Mounjaro causing constipation is connected to how the medicine works, the short answer is yes: stools become harder and less frequent, and passing them may feel more effortful than usual.

This is not a sign that something has gone wrong. It is a predictable consequence of how the medicine works, and it is listed clearly in the NHS patient information for tirzepatide. Knowing the cause matters because it points directly to the practical response: if movement through the gut has slowed, the factors that naturally support gut motility (fluid, fibre and physical movement) become more important, not less.

Understanding what Mounjaro constipation looks like in practice can help you recognise whether what you are experiencing fits the expected pattern, which tends to be most noticeable after starting treatment or after a dose increase, when the gut is adapting. For many people it settles within a couple of weeks. For others, particularly at higher doses, it stays present at a low level throughout treatment. Both patterns are within the range of what prescribers see regularly.

Step 2: Practical steps people discuss with their prescribers

The NHS England guidance on weight-management injections recommends discussing any persistent side effects with your clinical team rather than self-managing in silence. With that firmly in place, the practical approaches most often raised in those conversations include adequate fluid intake (many people on Mounjaro eat and drink significantly less, which can tip the balance toward dehydration), increasing dietary fibre gradually, and maintaining gentle exercise, all of which support normal bowel function.

One thing worth building into your weekly routine: some people find it helpful to keep a small note in the same place they store their pen (perhaps inside the fridge door alongside it) of the day they injected and how their digestion has been. Patterns are easier to spot, and easier to describe to a prescriber, when they are written down rather than recalled from memory.

Over-the-counter options such as osmotic laxatives are something many people ask about; whether any of those are appropriate for you is a clinical question, not one to answer based on a webpage. If you are already taking other medicines, your prescriber needs to know before you add anything new. The Mounjaro Patient Information Leaflet on the eMC covers interactions and what to report.

Step 3: Recognising when constipation on Mounjaro needs urgent attention

Ordinary constipation is uncomfortable but not dangerous. The signs that should prompt you to seek medical help promptly are different in character: severe abdominal pain, pain that radiates to your back, bloating that does not ease, vomiting alongside gut symptoms, or any signs of blood in the stool. These are not features of straightforward constipation and should not be waited out.

In January 2026 the MHRA issued a Drug Safety Update noting that acute pancreatitis is a known, though infrequent, side effect of GLP-1 medicines, and its early presentation can resemble severe constipation or abdominal pain. The MHRA asks that patients and clinicians remain alert to persistent, severe stomach pain, including pain that reaches the back. If in doubt, seek medical assessment the same day rather than waiting to see whether it passes.

You can also report any side effect you suspect is connected to Mounjaro directly through the MHRA's Yellow Card scheme. Reports from patients are taken seriously and contribute to post-market safety monitoring for newer medicines like tirzepatide, which carries a Black Triangle (▼) status indicating it is subject to additional surveillance.

For a broader picture of what to expect from the medicine, the full Mounjaro side-effects overview covers the complete profile in more detail. Questions about gallbladder health (another area of monitoring on tirzepatide) are addressed separately on the page covering Mounjaro after gallbladder removal.

Step 4: Having the conversation with a prescriber

A question that comes up frequently is whether Mounjaro constipation goes away over time, and it is one our prescribers at nume discuss regularly as part of the consultation process, both at the initial assessment and during clinical review before each repeat order. No repeat is processed automatically; a prescriber looks at the current picture, which includes how you are tolerating the medicine, before anything is approved or dispatched.

If constipation is significantly affecting your daily life, or if you are unsure whether what you are experiencing is within the expected range, that is exactly the kind of thing to raise via aftercare rather than managing alone. Our clinical team is available seven days a week. You can also find answers to common questions on the nume FAQs page or reach us directly through the contact page.

If you are considering starting treatment and want to understand why Mounjaro causes constipation and what that means before you begin, the free consultation page sets out each step clearly. A prescriber reviews suitability, discusses your medical history, and goes through what to expect (including the side-effect profile) before any prescription is issued. Check your eligibility and start that conversation at no cost.